Welcome to our dedicated page for Inflection Point Acquisition IV SEC filings (Ticker: BACQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Inflection Point Acquisition Corp. IV (BACQ) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as a Nasdaq-listed blank check company. Inflection Point Acquisition Corp. IV, a Cayman Islands exempted company and emerging growth company, files current and periodic reports with the U.S. Securities and Exchange Commission that describe its capital structure, governance and proposed business combination activities.
Among the key documents available are multiple Forms 8-K detailing material events. A filing dated September 23, 2025 describes the Business Combination Agreement between Bleichroeder Acquisition Corp. I (which will be renamed Inflection Point Acquisition Corp. IV), a merger subsidiary and Merlin Labs, Inc., a developer of assured, autonomous flight technology for defense customers. This 8-K also discusses a strategic partnership between Merlin Labs and GE Aerospace and notes that Inflection Point Acquisition Corp. IV and Merlin Labs are contemplating additional private placement financing in connection with the business combination.
An 8-K dated October 21, 2025 reports shareholder approval of changing the company’s name to Inflection Point Acquisition Corp. IV and amending its articles to modify redemption timing for public shares. Another 8-K dated November 17, 2025 outlines amendments to a Securities Purchase Agreement and additional securities purchase agreements that increase PIPE commitments for preferred stock and warrants to be issued by New Merlin Labs in connection with the transaction.
Through this filings page, users can review these 8-Ks, the definitive proxy statement on Schedule 14A regarding the name change and article amendments, and future registration statements on Form S-4 related to the proposed business combination. Stock Titan enhances this access with AI-powered summaries that highlight the main terms of the business combination, changes to shareholder rights, and details of PIPE and pre-funded note financings, helping readers interpret BACQ’s SPAC-related disclosures more efficiently.
Inflection Point Acquisition Corp. IV reported that shareholders approved all proposals presented at an extraordinary general meeting connected to its planned business combination with Merlin Labs, Inc., as described in its proxy statement/prospectus. The meeting achieved a quorum with 20,358,101 ordinary shares, or 60.31% of those outstanding as of February 2, 2026, represented in person or by proxy.
Each proposal received substantially more votes "for" than "against," and the company did not need to use an adjournment proposal because support levels were sufficient. Shareholders also backed the company’s slate of directors, with each nominee receiving significantly more votes "for" than votes withheld.
Inflection Point Acquisition Corp. IV discloses Merlin Labs completed the Preliminary Design Review (PDR) for its C-130J autonomy program. The PDR approval is part of a $105 million Indefinite Delivery, Indefinite Quantity contract and clears the way to enter the Critical Design phase.
Merlin states its preliminary integration design and airworthiness approach for demonstration were approved, and next steps include system integration, ground testing, and takeoff-to-touchdown flight demonstrations.
INFLECTION POINT ACQUISITION CORP. IV reported mixed insider trading activity by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC in its Class A common stock. Between November 28 and December 9, 2025, Goldman Sachs, acting as a market maker, executed multiple open-market purchases and sales.
The transactions totaled 4,328 shares purchased and 4,872 shares sold, for a small net sale of 544 shares, at prices generally around $10.71–$11.00 per share. After these trades, indirect ownership stood at roughly 3.25 million shares.
The common stock is held directly by Goldman Sachs and indirectly by The Goldman Sachs Group, Inc., which disclaim beneficial ownership except to any pecuniary interest. They state that any profit potentially recoverable under Section 16(b) from these trades will be remitted to the issuer, and that on February 5, 2026, they ceased to be greater-than-10% beneficial owners of the Class A common stock.
Inflection Point Acquisition Corp. disclosed an update on its previously announced business combination with Merlin Labs, Inc., noting that Merlin will host an Investor & Analyst Webinar on March 3, 2026 at 1:00pm ET featuring a presentation and Q&A with management.
The filing reiterates that the merger remains subject to the terms of the Business Combination Agreement and references a filed Form S-4 and a definitive proxy statement/prospectus that has been mailed to Inflection Point shareholders for their consideration.
Inflection Point Acquisition Corp. IV filed an 8-K highlighting a press release from Merlin Labs, Inc., its proposed merger partner, announcing an Investor & Analyst Webinar on March 3, 2026 at 1:00pm ET. The event will feature a presentation and Q&A with Merlin’s management, with a replay available on Merlin’s investor relations website.
The filing reiterates that Inflection Point and Merlin entered into a Business Combination Agreement on August 13, 2025 and that a Form S-4 registration statement with a proxy statement/prospectus has been filed and mailed to Inflection Point shareholders for their vote on the business combination. Merlin is described as an aerospace and defense technology company focused on autonomous flight, supported by $100M+ total in awarded contracts from military customers.
Merus Global Investments, LLC filed an amended Schedule 13G reporting a passive ownership position in Inflection Point Acquisition Corp. IV Class A ordinary shares. Merus beneficially owns 1,725,000 shares, representing 6.9% of the class, based on 25,000,000 shares outstanding as of February 2, 2026.
Merus reports sole voting and dispositive power over all 1,725,000 shares and no shared power. The firm certifies the securities were not acquired to change or influence control of the issuer, indicating a non‑control, investment-focused holding as of the December 31, 2025 event date.
Highbridge Capital Management, LLC filed a Schedule 13G reporting a significant passive ownership position in Inflection Point Acquisition Corp. IV. Highbridge, as investment adviser to certain funds and accounts, reported beneficial ownership of 2,011,897 Class A ordinary shares.
This stake represents 7.9% of the Class A ordinary shares outstanding, based on 25,425,000 Class A ordinary shares outstanding as of November 12, 2025, as disclosed by the issuer. Highbridge reported sole voting and sole dispositive power over the 2,011,897 shares, with no shared voting or dispositive power.
The filing notes that the shares are directly held by funds it advises, including Highbridge Tactical Credit Master Fund, L.P., which alone has the right to receive dividends or sale proceeds from more than 5% of the outstanding Class A ordinary shares. Highbridge certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of the company.
Inflection Point Acquisition Corp. IV received an updated Schedule 13G/A showing institutional holders reporting small, non‑controlling stakes in its Class A ordinary shares. As of December 31, 2025, First Trust Merger Arbitrage Fund reported beneficial ownership of 492,451 Ordinary Shares, or about 1.93% of the class. First Trust Capital Management L.P., First Trust Capital Solutions L.P., and FTCS Sub GP LLC collectively reported beneficial ownership of 593,278 Ordinary Shares, or 2.33% of the class. The filers state the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report passive ownership of Class A ordinary shares of Inflection Point Acquisition Corp. IV. They beneficially own 3,244,391 Class A shares, representing 12.8% of the class, with shared voting and shared dispositive power over all reported shares.
The filing is made on Schedule 13G, which is used for investments held in the ordinary course of business. The reporting persons certify the holdings were not acquired and are not held to change or influence control of the company.
Inflection Point Acquisition Corp. IV filed an amended S-4/proxy to register up to 164,748,772 shares of New Merlin Common Stock in connection with its proposed business combination with Merlin Labs, Inc., along with 10,288,021 shares of Series A Preferred Stock, New Merlin Series A Warrants, 25,425,000 rights and 453,821 units.
The deal values Merlin at a purchase price of $800,000,000, with Merlin equity holders receiving New Merlin Common Stock based on a share exchange ratio tied to the SPAC’s per‑share trust redemption price. Pre‑Funded PIPE investors previously provided about $87.3 million in convertible notes and warrants, and additional PIPE investors committed $120 million for Series A Preferred Stock and warrants.
Inflection Point will domesticate from the Cayman Islands to Delaware, be renamed “Merlin, Inc.”, and seek Nasdaq listing under the symbol “MRLN”, although the listing condition may be waived, meaning the combined company’s stock might trade off-exchange. Public shareholders can redeem their Class A shares for cash (about $10.52 per share as of the record date) regardless of how they vote, but high redemptions and sponsor/insider equity and fees may significantly dilute non‑redeeming holders.